Pelthos Therapeutics Inc. (PTHS) reported Q3 result

Go back to Pelthos Therapeutics Inc. (PTHS) reported Q3 result
(NYSE: PTHS) Delayed: 27.50 -1.45 (5.01%)
Previous Close $28.95    52 Week High
Open $28.00    52 Week Low
Day High $28.63    P/E N/A 
Day Low $26.97    EPS
Volume 23,287